BALA CYNWYD, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as ...

Larimar Therapeutics (LRMR) announced 25 mg and 50 mg data from the ongoing long-term open label study evaluating daily subcutaneous injections of nomlabofusp self-administered or administered by a ...

In 4 completed studies and the ongoing OL study, 65 participants received at least 1 dose of nomlabofusp, including 39 in the OL study, with 14 on treatment for at least 6 months and 8 for over 1 year ...

Barahona.-About 200 kilometers southwest of Santo Domingo, over 700 miners work in the world’s only larimar mine, a rare bluish semiprecious stone unique to the Dominican Republic. The mine, located ...

Larimar Therapeutics, Inc. (NASDAQ:LRMR) is poised at a critical juncture as it prepares to unveil crucial data for its flagship drug candidate, nomlabofusp, a potential treatment for Friedreich’s ...

Larimar’s cash position is now approximately $185 million, expected to sustain operations into the fourth quarter of 2026. These developments reflect the company’s strategic financial maneuvers in the ...

The Ministry of Energy and Mines has announced that in a landmark achievement for the Dominican Republic, the World Intellectual Property Organization (WIPO) has granted the country the International ...

Nonclinical findings provide evidence of the mechanism of action of nomlabofusp and support the potential use of skin FXN concentrations as a novel surrogate endpoint for Larimar’s planned BLA ...

BALA CYNWYD, Pa., July 08, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...